<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<?covid-19-tdm?>
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title>Frontiers in Physiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Physiol.</abbrev-journal-title>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1078763</article-id>
<article-id pub-id-type="doi">10.3389/fphys.2022.1078763</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>COVID-19 and athletes: Endurance sport and activity resilience study&#x2014;CAESAR study</article-title>
<alt-title alt-title-type="left-running-head">&#x15a;li&#x17c; et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2022.1078763">10.3389/fphys.2022.1078763</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>&#x15a;li&#x17c;</surname>
<given-names>Daniel</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wiecha</surname>
<given-names>Szczepan</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1324892/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ulaszewska</surname>
<given-names>Katarzyna</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2075254/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>G&#x105;sior</surname>
<given-names>Jakub S.</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/278076/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lewandowski</surname>
<given-names>Marcin</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kasiak</surname>
<given-names>Przemys&#x142;aw Seweryn</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1736966/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mamcarz</surname>
<given-names>Artur</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>3rd Department of Internal Diseases and Cardiology</institution>, <institution>Medical University of Warsaw</institution>, <addr-line>Warsaw</addr-line>, <country>Poland</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Students&#x2019; Scientific Group of Lifestyle Medicine</institution>, <institution>3rd Department of Internal Medicine and Cardiology</institution>, <institution>Medical University of Warsaw</institution>, <addr-line>Warsaw</addr-line>, <country>Poland</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Polish Society of Lifestyle Medicine</institution>, <addr-line>Warsaw</addr-line>, <country>Poland</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>School of Public Health</institution>, <institution>Postgraduate Medical Education Center</institution>, <addr-line>Warsaw</addr-line>, <country>Poland</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Physical Education and Health in Biala Podlaska</institution>, <institution>Faculty in Biala Podlaska</institution>, <institution>Jozef Pilsudski University of Physical Education in Warsaw</institution>, <addr-line>Biala Podlaska</addr-line>, <country>Poland</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Department of Pediatric Cardiology and General Pediatrics</institution>, <institution>Medical University of Warsaw</institution>, <addr-line>Warsaw</addr-line>, <country>Poland</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Department of Pharmacology and Clinical Pharmacology Collegium Medicum</institution>, <institution>Cardinal Stefan Wyszy&#x144;ski University in Warsaw</institution>, <addr-line>Warsaw</addr-line>, <country>Poland</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/311958/overview">Hamdi Chtourou</ext-link>, University of Sfax, Tunisia</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1687894/overview">Sven Fikenzer</ext-link>, University Hospital Leipzig, Germany</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/609166/overview">Barbara Ruaro</ext-link>, University of Trieste, Italy</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Szczepan Wiecha, <email>szczepan.wiecha@awf.edu.pl</email>; Przemys&#x142;aw Seweryn Kasiak, <email>przemyslaw.kasiak@wum.edu.pl</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Exercise Physiology, a section of the journal Frontiers in Physiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>12</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>1078763</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>10</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>12</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 &#x15a;li&#x17c;, Wiecha, Ulaszewska, G&#x105;sior, Lewandowski, Kasiak and Mamcarz.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>&#x15a;li&#x17c;, Wiecha, Ulaszewska, G&#x105;sior, Lewandowski, Kasiak and Mamcarz</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<bold>Background:</bold> The COVID-19 pandemic and imposed restrictions influenced athletic societies, although current knowledge about mild COVID-19 consequences on cardiopulmonary and physiologic parameters remains inconclusive. This study aimed to assess the impact of mild COVID-19 inflection on cardiopulmonary exercise test (CPET) performance among endurance athletes (EA) with varied fitness level.</p>
<p>
<bold>Materials and Methods:</bold> 49 EA (n<sub>male</sub> &#x3d; 43, n<sub>female</sub> &#x3d; 6, mean age &#x3d; 39.94 &#xb1; 7.80&#xa0;yr, height &#x3d; 178.45&#xa0;cm, weight &#x3d; 76.62&#xa0;kg; BMI &#x3d; 24.03&#xa0;kgm<sup>&#x2212;2</sup>) underwent double treadmill or cycle ergometer CPET and body analysis (BA) pre- and post-mild COVID-19 infection. Mild infection was defined as: (1) without hospitalization and (2) without prolonged health complications lasting for &#x3e;14&#xa0;days. Speed, power, heart rate (HR), oxygen uptake (VO<sub>2</sub>), pulmonary ventilation, blood lactate concentration (at the anaerobic threshold (AT)), respiratory compensation point (RCP), and maximum exertion were measured before and after COVID-19 infection. Pearson&#x2019;s and Spearman&#x2019;s r correlation coefficients and Student t-test were applied to assess relationship between physiologic or exercise variables and time.</p>
<p>
<bold>Results:</bold> The anthropometric measurements did not differ significantly before and after COVID-19. There was a significant reduction in VO<sub>2</sub> at the AT and RCP (both <italic>p</italic> &#x3c; 0.001). Pre-COVID-19 VO<sub>2</sub> was 34.97 &#xb1; 6.43&#xa0;ml&#xa0;kg&#xb7;min<sup>&#x2212;1</sup>, 43.88 &#xb1; 7.31&#xa0;ml&#xa0;kg&#xb7;min<sup>&#x2212;1</sup> and 47.81 &#xb1; 7.81&#xa0;ml&#xa0;kg&#xb7;min<sup>&#x2212;1</sup> respectively for AT, RCP and maximal and post-COVID-19 VO<sub>2</sub> was 32.35 &#xb1; 5.93&#xa0;ml&#xa0;kg&#xb7;min<sup>&#x2212;1</sup>, 40.49 &#xb1; 6.63&#xa0;ml&#xa0;kg&#xb7;min<sup>&#x2212;1</sup> and 44.97 &#xb1; 7.00&#xa0;ml&#xa0;kg&#xb7;min<sup>&#x2212;1</sup> respectively for AT, RCP and maximal. Differences of HR at AT (<italic>p</italic> &#x3c; 0.001) and RCP (<italic>p</italic> &#x3c; 0.001) was observed. The HR before infection was 145.08 &#xb1; 10.82&#xa0;bpm for AT and 168.78 &#xb1; 9.01&#xa0;bpm for RCP and HR after infection was 141.12 &#xb1; 9.99&#xa0;bpm for AT and 165.14 &#xb1; 9.74&#xa0;bpm for RCP. Time-adjusted measures showed significance for body fat (r &#x3d; 0.46, <italic>p</italic> &#x3c; 0.001), fat mass (r &#x3d; 0.33, <italic>p</italic> &#x3d; 0.020), cycling power at the AT (r &#x3d; &#x2212;0.29, <italic>p</italic> &#x3d; 0.045), and HR at RCP (r &#x3d; &#x2212;0.30, <italic>p</italic> &#x3d; 0.036).</p>
<p>
<bold>Conclusion:</bold> A mild COVID-19 infection resulted in a decrease in EA&#x2019;s CPET performance. The most significant changes were observed for VO<sub>2</sub> and HR. Medical Professionals and Training Specialists should be aware of the consequences of a mild COVID-19 infection in order to recommend optimal therapeutic methods and properly adjust the intensity of training.</p>
</abstract>
<kwd-group>
<kwd>physical activity</kwd>
<kwd>CPET cardiopulmonary exercise testing</kwd>
<kwd>VO<sub>2max</sub> (maximal oxygen uptake)</kwd>
<kwd>endurance athlete</kwd>
<kwd>SARS-CoV-2</kwd>
<kwd>COVID-19</kwd>
</kwd-group>
<contract-sponsor id="cn001">Warszawski Uniwersytet Medyczny<named-content content-type="fundref-id">10.13039/501100004166</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>It was calculated that 18.2&#xa0;million people died as a result of the pandemic between 2020 and 2021 and numerous deaths were due to coronavirus disease 2019 (COVID-19) (<xref ref-type="bibr" rid="B44">Wang et al., 2022</xref>). The numbers were influenced by limited prevention and treatment measures aimed at other diseases. In the case of convalescents, persistent symptoms are common after the infection (<xref ref-type="bibr" rid="B29">Nasserie et al., 2021</xref>). To mention, one of the most important health consequences of COVID-19 infection are CT changes in the respiratory system, primarily lunges (<xref ref-type="bibr" rid="B5">Baratella et al., 2021</xref>). Although, physical activity prior COVID-19 might alleviate severity and reduce mortality range in COVID-19 patients. It is especially recommended to include physical activity in the amount of &#x2265;150&#xa0;min/week of moderate activity or &#x2265;75&#xa0;min/week of vigorous activity (<xref ref-type="bibr" rid="B38">Sittichai et al., 2022</xref>). Even full vaccination does not guarantee complete protection against long-lasting COVID-19 complications (<xref ref-type="bibr" rid="B2">Al-Aly et al., 2022</xref>).</p>
<p>The period of pandemic and the anxiety associated with it made a huge impact on the lifestyle of people around the world (<xref ref-type="bibr" rid="B17">Jodczyk et al., 2021</xref>; <xref ref-type="bibr" rid="B18">Jodczyk et al., 2022</xref>). Many areas of human life were negatively affected, including mental health (<xref ref-type="bibr" rid="B14">Gruba et al., 2021</xref>; <xref ref-type="bibr" rid="B18">Jodczyk et al., 2022</xref>). Depression, anxiety disorders, sleep disturbances, and perceived stress became more common compared to the period before COVID-19, both among healthy young individuals and those yet suffering from any diseases (<xref ref-type="bibr" rid="B20">Kasiak et al., 2022a</xref>). The shift in everyday routine also elicited reports of decreased physical activity in different populations (<xref ref-type="bibr" rid="B48">Wunsch et al., 2022</xref>).</p>
<p>New, pandemic conditions became a challenge for sportsmen. Although, athletes are not considered a high-risk group for high COVID-19 vaccine hesitancy (<xref ref-type="bibr" rid="B42">Ulaszewska et al., 2022</xref>). Moreover, about 94% of them, the course of the illness is asymptomatic or mild (<xref ref-type="bibr" rid="B24">Lemes et al., 2022</xref>). Nevertheless, the return to physical activity after the disease raised questions in terms of safety with myocardial involvement as the main concern (<xref ref-type="bibr" rid="B31">Rajpal et al., 2021</xref>; <xref ref-type="bibr" rid="B27">Modica et al., 2022</xref>). Health hazards other than cardiovascular sequelae include respiratory (<xref ref-type="bibr" rid="B49">Xia et al., 2020</xref>) or muscular (<xref ref-type="bibr" rid="B36">Seixas et al., 2022</xref>) complications. Although, these health complications do not always require hospitalization. Moreover, training in confined areas (<xref ref-type="bibr" rid="B45">Washif et al., 2022</xref>) and sports events (<xref ref-type="bibr" rid="B39">Sparrow et al., 2021</xref>) encountered significant organizational problems due to the risk of SARS-CoV-2 transmission.</p>
<p>The above-mentioned factors remain closely related to physical performance. There is evidence of reduced oxygen uptake (VO<sub>2</sub>) and altered lactate metabolism in athletic convalescents after mild COVID-19. This issue is still not enough studied, but the physical capacity of the subjects tended to decline (<xref ref-type="bibr" rid="B8">Csulak et al., 2021</xref>; <xref ref-type="bibr" rid="B22">Komici et al., 2021</xref>). There is also a study whose results deviate from this assumption (<xref ref-type="bibr" rid="B10">Fikenzer et al., 2021</xref>). Cardiopulmonary exercise testing (CPET) has proven to be a useful tool in evaluating endurance athletes after COVID-19 and could be used to diagnose persisting symptoms (<xref ref-type="bibr" rid="B28">Moulson et al., 2022</xref>).</p>
<p>We stipulate that COVID-19 infection causes a deterioration in fitness performance with the aggravation of the body&#x2019;s physiology and anthropometric measures (<xref ref-type="bibr" rid="B3">Ali and Kunugi, 2021</xref>), changes are noted especially in muscle building, the mechanism is not clear, but it may be due to e.g., the cytokine storm, malnutrition, prolonged inactivity (<xref ref-type="bibr" rid="B51">Zhou et al., 2020</xref>). This study aimed to: (1) assess COVID-19 consequences among endurance athletes with varied fitness level on exercise and body physiology and (2) adjust obtained results to time passed from COVID-19 infection. The main novelty and advantage of the present study is providing time adjusted results of CPET performance and somatic changes depending on the time that has passed since the COVID-19 infection. This approach enable to better understand possible consequences of the underwent disease. Moreover, we included EA with varied level of advancement, both professional and amateur ones, which facilitate more holistic and comprehensive assessment of COVID-19 infection on CPET performance.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and methods</title>
<sec id="s2-1">
<title>Study sample and testing protocol</title>
<p>This study was carried out on a group of young endurance athletes from June 2021 to June 2022 at the Tertiary Care Centre Sports Medicine Clinic (<ext-link ext-link-type="uri" xlink:href="http://www.sportslab.pl/">www.sportslab.pl</ext-link>; accessed on 2 February 2022, Warsaw, Poland). The recruitment process involved only endurance athletes who underwent a CPET performed pre and post-COVID-19 infection. Each participant signed informed consent. Study sample consisted of individuals with varied fitness level, both professional and amateur EAs.</p>
<p>The participants&#x2019; selection process has been shown in <xref ref-type="fig" rid="F1">Figure 1</xref>. The inclusion criteria included: treadmill or cycle ergometer CPET in the 3&#xa0;years before SARS-CoV-2 inflection, SARS-CoV-2 infection confirmed by PCR or antigen test, lack of hospitalization in a period from 2&#xa0;weeks up to 6&#xa0;months before post-COVID-19 CPET, asymptomatic or mild course of the disease with no persisting symptoms for &#x3e;14&#xa0;days, actual negative SARS-CoV-2 PCR or antigen test. The exclusion criteria included: respiratory diseases (COPD, poorly controlled bronchial asthma, blood saturation &#x3c;95%), cardiovascular diseases (cardiac arrhythmias confirmed by ECG, myocardial ischemia, prolongation of the QT interval in the ECG, any structural disorders of the heart found in echocardiography, decompensated hypertension with blood pressure over 160/100&#xa0;mmHg), acute neurological and psychiatric conditions, acute or chronic musculoskeletal condition, deviations in laboratory tests (leukocytosis over 10,000&#xa0;mm<sup>&#x2212;3</sup>, anemia with hemoglobin levels &#x3c;10&#xa0;g&#xb7;dL<sup>&#x2212;1</sup>dl).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Participants selection protocol. Abbreviations: EA, endurance athlete; CPET, cardiopulmonary exercise test; ECG, 12-lead electrocardiogram; CBC, complete blood count; COPD, Chronic obstructive pulmonary disease; HB, blood hemoglobin.</p>
</caption>
<graphic xlink:href="fphys-13-1078763-g001.tif"/>
</fig>
<p>Participants had a pre-CPET medical appointment with the cardiologist. A medical professional examined their past medical history and performed a physical examination, supplemented with a 12-lead ECG and echocardiography. Only athletes without cardiac or pulmonary abnormalities were finally qualified for the study.</p>
<p>43 males and 6 females fulfilled all inclusion criteria. Athletes underwent a treadmill or cycle ergometer CPET (a protocol and machine identical to the one used before the SARS-CoV-2 infection).</p>
</sec>
<sec id="s2-2">
<title>CPET protocol</title>
<p>Body composition analysis (BA) was analyzed with a Tanita device (Tanita, MC 718, Japan) prior to each CPET with multifrequency 5&#xa0;kHz/50&#xa0;kHz/250&#xa0;kHz. BA and CPET were conducted under the same conditions: 40&#xa0;m<sup>2</sup> air-conditioned area, altitude 100&#xa0;m, MSL temperature 20&#x2013;22&#xb0;C, humidity 40&#x2013;60%. Participants received dietary and recovery recommendations <italic>via</italic> e-mail prior to the CPET to be prepared well. Cycle CPET was performed on Cyclus-2 (RBM elektronik-automation GmbH, Leipzig, Germany), while treadmill on a mechanical treadmill (h/p/Cosmos quasar, Germany). Post-COVID-19 CPET was on the same modality as the pre-COVID-19. Cardio-pulmonary indices were measured <italic>via</italic> Cosmed Quark CPET device (Rome, Italy), and adjusted individually before each test (as recommended by the manufacturer&#x2019;s instructions). HR was measured with the usage of the ANT &#x2b; chest strap (as part of the Cosmed Quark CPET set) with accuracy comparable to ECG, &#xb1;1&#xa0;bpm. For each athlete, the starting power (Watt) or speed (km/h) was individually determined. The starting power for the cycle ergometer CPET was the lowest value at which the participant declared resistance. For the treadmill, the initial speed was a &#x201a;conversation&#x2019; pace. The test began with 5&#xa0;min warm-up (walking or pedaling without resistance). The velocity was raised each 2&#xa0;min by 1&#xa0;km/h or the power by 20&#x2013;30&#xa0;W. For the treadmill CPET inclination was set at 1%. To obtain the maximum level of symptom-free exertion, sportsmen were instructed to maintain the effort as long as possible. They could end the protocol at any moment if felt they had reached their maximum. To ensure that participants achieved maximal effort, only those who&#x2019;s met &#x2265;4 the following criteria were included: (1) RER &#x2265;1.10, (2) presented VO<sub>2</sub> plateau (a VO<sub>2</sub> growth &#x3c;100&#xa0;ml&#xa0;min<sup>&#x2212;1</sup> with increasing speed/power), (3) f<sub>R</sub> &#x3e;45&#xa0;min<sup>&#x2212;1</sup>, and (4) declared exertion &#x2265;18 according to the Borg scale, (5) highest achieved HR <bold>&#x2264;</bold> 15&#xa0;bpm under predicted HR<sub>max</sub> (<xref ref-type="bibr" rid="B23">Lach et al., 2021</xref>). The exercises were terminated externally if VO<sub>2</sub> or HR no further increase with increasing speed or power. CPET measures were by breath-by-breath method. VO<sub>2max</sub> was averaged across 10-s intervals directly before termination. The peak HR was used in the analysis and the HR values were not averaged. Blood lactate was measured by obtaining 20&#xa0;&#x3bc; L blood sample from the fingertip. The measures were conducted before the test, after intensity change and 3&#xa0;min after termination and analyzed in Super GL2 analyzer (Muller Geratebau 157 GmbH, Freital, Germany). First drops were taken into a swab before the proper sample has been taken. AT was considered after fulfilling all the following criteria: (1) VE/VO<sub>2</sub> curve increased with the stable VE/VCO<sub>2</sub> curve and (2) the end-tidal O<sub>2</sub> partial pressure increase with the stable end-tidal CO<sub>2</sub> partial pressure. RCP was considered after fulfilling all the following criteria: (1) a decrease in end-tidal CO<sub>2</sub> partial pressure after achieving a maximal exertion; (2) a rapid increase in VE (second deflection); (3) the VE/VCO<sub>2</sub> proportion meets the lowest value and begin to increase, and (4) a increase in VCO<sub>2</sub> compared to VO<sub>2</sub> (divergence from linearity).</p>
</sec>
<sec id="s2-3">
<title>Statistical analysis</title>
<p>Basic participants&#x2019; data were anonymized, exported, and saved as an Excel file (Microsoft Corporation, Washington, DC, United States. The Shapiro-Wilk test was performed to assess normality. All variables were considered as continuous and calculated as means with standard derivation (SD). For normally distributed data Pearson&#x2019;s r correlation coefficient was applied and for non-normally distributed variables the Spearman rank correlation coefficient was used. To compare means between the most significant variables adjusted for training experience, additional Student t-test for independent means heave been performed. The significance borderline was set at <italic>p</italic> &#x3d; 0.05. Analyses were performed with the usage of statistical software SPSS Statistics (version 28, IBM, Chicago, IL, United States) and STATISTICA (version 13.3, StatSoft Polska Sp.z. o.o., Krak&#xf3;w, Poland).</p>
</sec>
<sec id="s2-4">
<title>Ethics</title>
<p>This study was approved by the Bioethics Committee of the Medical University of Warsaw (approval no. KB/50/21 from 19th April 2021). Study procedures were in line with the declaration of Helsinki. Each athlete got detailed study information and signed informed consent before participating in the protocol.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Participants basic characteristics</title>
<p>The characteristics of the population, including data such as height, weight, BMI, fat-free mass), BF (body fat), and FATM (fat mass), are presented in <xref ref-type="table" rid="T1">Table 1</xref>. Mean age during post-COVID-19 evaluation was 39.94 &#xb1; 7.80&#xa0;years (40.74 &#xb1; 6.98&#xa0;years for males and 38.09 &#xb1; 6.43 for females). We noticed the weight and BMI increases. Interestingly, the percentage of BF and FATM is lower after contracting COVID-19.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Participants characteristics.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="3" align="center">Variable</th>
<th align="center">Males (<italic>n</italic> &#x3d; 43)</th>
<th align="center">Females (<italic>n</italic> &#x3d; 6)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td colspan="3" align="left">Age</td>
<td align="center">40.74 &#xb1; 6.98</td>
<td align="center">38.09 &#xb1; 6.43</td>
</tr>
<tr>
<td colspan="3" align="left">Height</td>
<td align="center">178.45 &#xb1;a 6.81</td>
<td align="center">178.39 &#xb1; 6.85</td>
</tr>
<tr>
<td rowspan="2" align="left">CPET modality</td>
<td colspan="2" align="left">Treadmill</td>
<td align="center">25 (51.02%)</td>
<td align="center">4 (8.16%)</td>
</tr>
<tr>
<td colspan="2" align="left">Cycle ergometer</td>
<td align="center">16 (32.65%)</td>
<td align="center">2 (4.08%)</td>
</tr>
<tr>
<td colspan="3" align="left">Interval between CPET</td>
<td colspan="2" align="center">591.67 &#xb1; 282.24</td>
</tr>
<tr>
<td colspan="3" align="left">Interval between pre-COVID-19 CPET and negative PCR test (end of COVID-19)</td>
<td colspan="2" align="center">436.40 &#xb1; 290.40</td>
</tr>
<tr>
<td colspan="3" align="left">Interval between post-COVID-19 CPET and negative PCR test (end of COVID-19)</td>
<td colspan="2" align="center">155.27 &#xb1; 82.52</td>
</tr>
<tr>
<td rowspan="3" colspan="2" align="left">Primary sport discipline</td>
<td align="right">Running</td>
<td align="right">16 (32.65%)</td>
<td align="right">4 (8.16%)</td>
</tr>
<tr>
<td align="right">Cycling</td>
<td align="right">13 (26.53%)</td>
<td align="right">1 (2.04%)</td>
</tr>
<tr>
<td align="right">Other</td>
<td align="right">14 (28.57%)</td>
<td align="right">1 (2.04%)</td>
</tr>
<tr>
<td rowspan="2" colspan="2" align="left">Waived competition due to COVID-19 infection</td>
<td align="right">Yes</td>
<td align="right">21 (42.86%)</td>
<td align="right">2 (4.08%)</td>
</tr>
<tr>
<td align="right">No</td>
<td align="right">23 (46.94%)</td>
<td align="right">4 (8.16%)</td>
</tr>
<tr>
<td colspan="2" align="left"/>
<td align="center">Pre-COVID-19</td>
<td align="center">Post-COVID-19</td>
<td align="center">
<italic>p</italic>-value</td>
</tr>
<tr>
<td colspan="2" align="left">Weight</td>
<td align="right">76.62 &#xb1; 10.02</td>
<td align="right">76.66 &#xb1; 10.90</td>
<td align="right">0.951</td>
</tr>
<tr>
<td colspan="2" align="left">BMI</td>
<td align="right">24.03 &#xb1; 2.49</td>
<td align="right">24.04 &#xb1; 2.71</td>
<td align="right">0.931</td>
</tr>
<tr>
<td colspan="2" align="left">FFM</td>
<td align="right">63.36 &#xb1; 7.63</td>
<td align="right">63.45 &#xb1; 7.97</td>
<td align="right">0.774</td>
</tr>
<tr>
<td colspan="2" align="left">BF</td>
<td align="right">17.09 &#xb1; 4.73</td>
<td align="right">16.91 &#xb1; 5.12</td>
<td align="right">0.604</td>
</tr>
<tr>
<td colspan="2" align="left">FATM</td>
<td align="right">13.27 &#xb1; 4.68</td>
<td align="right">13.20 &#xb1; 5.23</td>
<td align="right">0.848</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Abbreviations: COVID-19, coronavirus disease 2019; BMI, body mass index (kg&#xb7;m<sup>-2</sup>); FFM, fat-free mass (kg); BF, body fat (%); FATM, fat mass (kg). Age is presented in years. Heigh is presented in cm. Weight is presented in kg. Intervals between CPETs is presented in days. Intervals between pre- and post-COVID-19 CPETs and PCR are presented in days</p>
</fn>
<fn>
<p>Data are presented as means with standard derivation (&#xb1;) for continuous variables and number with percentage (%) for categorical variables.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The anthropometric measurements did not differ substantially before and after COVID-19. Meanwhile, there was a significant change in CPET performance. Both VO<sub>2</sub> at the anaerobic threshold (VO<sub>2AT</sub>, <italic>p</italic> &#x3c; 0.00001) and VO<sub>2</sub> at the respiratory compensation point (VO<sub>2RCP</sub>, <italic>p</italic> &#x3c; 0.00001) differ between pre- and post-infection conditions. Relative and absolute values were lower during the post-infection assessment. Heart rate at the anaerobic threshold (HR<sub>AT</sub>, <italic>p</italic> &#x3d; 0.00140) and heart rate at the respiratory compensation point (HR<sub>RCP</sub>, <italic>p</italic> &#x3d; 0.00011) were also aggravated and higher values were noted for post-infection measurement. Whereas lactate concentration and pulmonary ventilation (VE) were decreased only at the respiratory compensation point (Lac<sub>RCP</sub>, <italic>p</italic> &#x3d; 0.01250, and VE<sub>RCP</sub>, <italic>p</italic> &#x3c; 0.00001). The maximal oxygen uptake (VO<sub>2max</sub>) was also diminished in the post-COVID-19 period (<italic>p</italic> &#x3d; 0.00012). Other measures at the anaerobic threshold, respiratory compensation point, or maximal parameters remained stable without significant differences. The precise results of pre- and post-infection measurements have been shown in <xref ref-type="table" rid="T2">Table 2</xref>. After adjusting HR for training experience particular groups did not differ significantly, except 6&#x2013;10&#xa0;years of training (<italic>p</italic> &#x3d; 0.03&#x2013;0.37 for AT and 0.02&#x2013;0.46 for RCP). Moreover, VO<sub>2</sub> did not differ significantly in any subgroup in model adjusted for training experience (<italic>p</italic> &#x3d; 0.25&#x2013;0.41 for AT, <italic>p</italic> &#x3d; 0.19&#x2013;0.49 for RCP and <italic>p</italic> &#x3d; 0.19&#x2013;0.46 for max).</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Differences between pre- and post- COVID-19 CPET for study population.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Variable</th>
<th align="center">Pre-COVID-19</th>
<th align="center">Post-COVID-19</th>
<th align="center">p-value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">VO<sub>2AT</sub>
</td>
<td align="right">
<bold>34.96 &#xb1; 6.49</bold>
</td>
<td align="right">
<bold>32.35 &#xb1; 5.99</bold>
</td>
<td align="right">
<bold>&#x3c;0.00001</bold>
</td>
</tr>
<tr>
<td align="left">VO<sub>2ATa</sub>
</td>
<td align="right">
<bold>2,650.00 &#xb1; 470.90</bold>
</td>
<td align="right">
<bold>2,446.10 &#xb1; 400.30</bold>
</td>
<td align="right">
<bold>&#x3c;0.00001</bold>
</td>
</tr>
<tr>
<td align="left">HR<sub>AT</sub>
</td>
<td align="right">
<bold>145.10 &#xb1; 10.90</bold>
</td>
<td align="right">
<bold>141.10 &#xb1; 10.10</bold>
</td>
<td align="right">
<bold>0.00140</bold>
</td>
</tr>
<tr>
<td align="left">VE<sub>AT</sub>
</td>
<td align="right">70.80 &#xb1; 18.70</td>
<td align="right">68.10 &#xb1; 14.70</td>
<td align="right">0.08950</td>
</tr>
<tr>
<td align="left">VO<sub>2RCP</sub>
</td>
<td align="right">
<bold>43.90 &#xb1; 7.40</bold>
</td>
<td align="right">
<bold>40.50 &#xb1; 6.70</bold>
</td>
<td align="right">
<bold>&#x3c;0.00001</bold>
</td>
</tr>
<tr>
<td align="left">VO<sub>2RCPa</sub>
</td>
<td align="right">
<bold>3,324.30 &#xb1; 512.90</bold>
</td>
<td align="right">
<bold>3,063.70 &#xb1; 440.10</bold>
</td>
<td align="right">
<bold>&#x3c;0.00001</bold>
</td>
</tr>
<tr>
<td align="left">HR<sub>RCP</sub>
</td>
<td align="right">
<bold>168.80 &#xb1; 9.20</bold>
</td>
<td align="right">
<bold>165.10 &#xb1; 9.80</bold>
</td>
<td align="right">
<bold>0.00011</bold>
</td>
</tr>
<tr>
<td align="left">VE<sub>RCP</sub>
</td>
<td align="right">
<bold>106.80 &#xb1; 21.70</bold>
</td>
<td align="right">
<bold>98.90 &#xb1; 18.30</bold>
</td>
<td align="right">
<bold>&#x3c;0.00001</bold>
</td>
</tr>
<tr>
<td align="left">Lac<sub>RCP</sub>
</td>
<td align="right">
<bold>4.88 &#xb1; 1.370</bold>
</td>
<td align="right">
<bold>4.34 &#xb1; 1.14</bold>
</td>
<td align="right">
<bold>0.01250</bold>
</td>
</tr>
<tr>
<td align="left">VO<sub>2max</sub>
</td>
<td align="right">
<bold>47.81 &#xb1; 8.00</bold>
</td>
<td align="right">
<bold>44.97 &#xb1; 7.07</bold>
</td>
<td align="right">
<bold>0.00012</bold>
</td>
</tr>
<tr>
<td align="left">VO<sub>2maxa</sub>
</td>
<td align="right">
<bold>3,623.47 &#xb1; 552.12</bold>
</td>
<td align="right">
<bold>3,406.00 &#xb1; 474.46</bold>
</td>
<td align="right">
<bold>&#x3c;0.00001</bold>
</td>
</tr>
<tr>
<td align="left">HR<sub>max</sub>
</td>
<td align="right">180.80 &#xb1; 10.08</td>
<td align="right">179.84 &#xb1; 9.96</td>
<td align="right">0.27330</td>
</tr>
<tr>
<td align="left">VE<sub>max</sub>
</td>
<td align="right">142.99 &#xb1; 26.89</td>
<td align="right">138.50 &#xb1; 23.93</td>
<td align="right">0.06830</td>
</tr>
<tr>
<td align="left">Lac<sub>max</sub>
</td>
<td align="right">9.71 &#xb1; 2.30</td>
<td align="right">9.64 &#xb1; 2.41</td>
<td align="right">0.87950</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Abbreviations: COVID-19, coronavirus disease 2019; VO<sub>2AT</sub>, oxygen uptake at the anaerobic threshold (ml&#xb7;kg&#xb7;min<sup>-1</sup>); VO<sub>2ATa</sub>, absolute oxygen uptake at the anaerobic threshold (ml&#xb7;min<sup>-1</sup>); HR<sub>AT</sub>, heart rate at the anaerobic threshold (beats&#xb7;min<sup>-1</sup>); VE<sub>AT</sub>, pulmonary ventilation at the anaerobic threshold (l&#xb7;min<sup>-1</sup>); VO<sub>2RCP</sub>, oxygen uptake at the respiratory compensation point (ml&#xb7;kg&#xb7;min<sup>-1</sup>); VO<sub>2RCPa</sub> absolute oxygen uptake at the respiratory compensation point (ml&#xb7;min<sup>-1</sup>); HR<sub>RCP</sub>, heart rate at the respiratory compensation point (beats&#xb7;min<sup>-1</sup>); VE<sub>RCP</sub> pulmonary ventilation at the respiratory compensation point (l&#xb7;min<sup>-1</sup>); Lac<sub>RCP</sub>, blood lactate concentration at the respiratory compensation point (mmol&#xb7;L<sup>-1</sup>); VO<sub>2max</sub>, maximal oxygen uptake (ml&#xb7;kg&#xb7;min<sup>-1</sup>); VO<sub>2maxa</sub>, absolute maximal oxygen uptake (ml&#xb7;kg&#xb7;min<sup>-1</sup>); HR<sub>max</sub>, maximal heart rate (beats&#xb7;min<sup>-1</sup>); VE<sub>max</sub>, maximal pulmonary ventilation (l&#xa0;min<sup>-1</sup>); Lac<sub>max</sub>, maximal blood lactate concentration (mmol&#xb7;L<sup>-1</sup>). Data are presented as means with standard derivation (&#xb1;). Significant values (<italic>p</italic> &#x3c; 0.05) were bolded.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-2">
<title>CPET results</title>
<p>Treadmill and cycle ergometer CPET revealed additional differences. On the cycle ergometer, only absolute VO<sub>2max</sub> was altered (<italic>p</italic> &#x3d; 0.039). Although, other variables showed changes without statistical significance-speed or power at the AT (<italic>p</italic> &#x3d; 0.066), speed or power at the RCP (<italic>p</italic> &#x3d; 0.061), and relative VO<sub>2max</sub> (<italic>p</italic> &#x3d; 0.078). Results of CPET performed on the cycle ergometry have been shown in <xref ref-type="table" rid="T3">Table 3</xref>. On the treadmill, both relative and absolute VO<sub>2max</sub> (<italic>p</italic> &#x3d; 0.00036 and 0.00003, respectively) and speed at AT and RCP (<italic>p</italic> &#x3d; 0.04450 and <italic>p</italic> &#x3d; 0.00019, respectively) presented significant differences. The results of CPET performed on the cycle ergometer have been presented in <xref ref-type="table" rid="T2">Table 2</xref>, while for a treadmill in <xref ref-type="table" rid="T4">Table 4</xref>.</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Differences between pre- and post- COVID-19 CPET for cycle ergometer.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Variable</th>
<th align="center">Pre-COVID-19</th>
<th align="center">Post-COVID-19</th>
<th align="center">p-value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Speed/power AT</td>
<td align="center">162.80 &#xb1; 25.90</td>
<td align="center">154.80 &#xb1; 25.90</td>
<td align="right">0.066</td>
</tr>
<tr>
<td align="left">Speed/power at RCP</td>
<td align="center">245.24 &#xb1; 41.99</td>
<td align="center">232.22 &#xb1; 39.71</td>
<td align="right">0.061</td>
</tr>
<tr>
<td align="left">Maximal speed/power</td>
<td align="center">310.00 &#xb1; 47.15</td>
<td align="center">312.22 &#xb1; 49.06</td>
<td align="right">0.811</td>
</tr>
<tr>
<td align="left">VO<sub>2max</sub>
</td>
<td align="center">45.27 &#xb1; 9.65</td>
<td align="center">42.73 &#xb1; 8.19</td>
<td align="right">0.078</td>
</tr>
<tr>
<td align="left">VO<sub>2maxa</sub>
</td>
<td align="center">
<bold>3,465.65 &#xb1; 566.51</bold>
</td>
<td align="center">
<bold>3,287.80 &#xb1; 466.96</bold>
</td>
<td align="right">0.039</td>
</tr>
<tr>
<td align="left">HR<sub>max</sub>
</td>
<td align="center">183.67 &#xb1; 10.67</td>
<td align="center">184.00 &#xb1; 11.04</td>
<td align="right">0.817</td>
</tr>
<tr>
<td align="left">VE<sub>max</sub>
</td>
<td align="center">142.59 &#xb1; 30.98</td>
<td align="center">138.05 &#xb1; 26.22</td>
<td align="right">0.297</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Abbreviations: COVID-19, coronavirus disease 2019; VO<sub>2max</sub>, maximal oxygen uptake (ml&#xb7;kg&#xb7;min<sup>-1</sup>); VO<sub>2maxa</sub>, absolute maximal oxygen uptake (ml&#xb7;kg&#xb7;min<sup>-1</sup>); HR<sub>max</sub>, maximal heart rate (beats&#xb7;min<sup>-1</sup>); VE<sub>max</sub>, maximal pulmonary ventilation (l&#xb7;min<sup>-1</sup>). Power is presented in Watts. Data are presented as means with standard derivation (&#xb1;). Significant values (<italic>p</italic> &#x3c; 0.05) were bolded. 18 athletes underwent CPET on a cycle ergometer.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T4" position="float">
<label>TABLE 4</label>
<caption>
<p>Differences between pre- and post- COVID-19 CPET for treadmill.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Variable</th>
<th align="center">Pre-COVID-19</th>
<th align="center">Post-COVID-19</th>
<th align="center">
<italic>p</italic>-value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Speed AT</td>
<td align="right">
<bold>11.43 &#xb1; 1.42</bold>
</td>
<td align="right">
<bold>11.11 &#xb1; 1.28</bold>
</td>
<td align="right">
<bold>0.04450</bold>
</td>
</tr>
<tr>
<td align="left">Speed at RCP</td>
<td align="right">
<bold>14.32 &#xb1; 1.48</bold>
</td>
<td align="right">
<bold>13.80 &#xb1; 1.53</bold>
</td>
<td align="right">
<bold>0.00019</bold>
</td>
</tr>
<tr>
<td align="left">Maximal speed</td>
<td align="right">16.58 &#xb1; 1.57</td>
<td align="right">16.39 &#xb1; 1.65</td>
<td align="right">0.26400</td>
</tr>
<tr>
<td align="left">VO<sub>2max</sub>
</td>
<td align="right">
<bold>49.29 &#xb1; 6.59</bold>
</td>
<td align="right">
<bold>46.27 &#xb1; 6.10</bold>
</td>
<td align="right">
<bold>0.00036</bold>
</td>
</tr>
<tr>
<td align="left">VO<sub>2maxa</sub>
</td>
<td align="right">
<bold>3,715.11 &#xb1; 531.27</bold>
</td>
<td align="right">
<bold>3,474.63 &#xb1; 472.61</bold>
</td>
<td align="right">
<bold>0.00003</bold>
</td>
</tr>
<tr>
<td align="left">HR<sub>max</sub>
</td>
<td align="right">179.13 &#xb1; 9.50</td>
<td align="right">177.42 &#xb1; 8.55</td>
<td align="right">0.12650</td>
</tr>
<tr>
<td align="left">VE<sub>max</sub>
</td>
<td align="right">143.23 &#xb1; 24.76</td>
<td align="right">138.88 &#xb1; 22.94</td>
<td align="right">0.14230</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Abbreviations: COVID-19, coronavirus disease 2019; AT, anaerobic threshold; RCP. respiratory compensation point; VO<sub>2max</sub>, maximal oxygen uptake (ml&#xb7;kg&#xb7;min<sup>-1</sup>); VO<sub>2maxa</sub>, absolute maximal oxygen uptake (ml&#xb7;kg&#xb7;min<sup>-1</sup>); HR<sub>max</sub>, maximal heart rate (beats&#xb7;min<sup>-1</sup>); VE<sub>max</sub>, maximal pulmonary ventilation (l&#xa0;min<sup>-1</sup>). Speed is presented in km&#xb7;h<sup>-1</sup>. Data are presented as means with standard derivation (&#xb1;). Significant values (<italic>p</italic> &#x3c; 0.05) were bolded. 31 athletes underwent CPET on a treadmill.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In further analysis, variables adjusted to time (calculated in days from COVID-19 infection to CPET) showed significance for BF, FATM, power at the AT, and HR<sub>RCP</sub>. Results of the time-adjusted COVID-19 consequences on CPET and physiologic variables have been presented in <xref ref-type="table" rid="T5">Tables 5</xref>, <xref ref-type="table" rid="T6">6</xref>.</p>
<table-wrap id="T5" position="float">
<label>TABLE 5</label>
<caption>
<p>Pearson&#x2019;s r correlation coefficients for CPET and physiologic results adjusted to time.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Variable</th>
<th align="center">r-Pearson</th>
<th align="center">
<italic>p</italic>-value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">BF &#x26; time [days]</td>
<td align="right">
<bold>0.456</bold>
</td>
<td align="right">
<bold>0.001</bold>
</td>
</tr>
<tr>
<td align="left">VO<sub>2AT</sub> &#x26; time [days]</td>
<td align="right">&#x2212;0.146</td>
<td align="right">0.317</td>
</tr>
<tr>
<td align="left">VO<sub>2ATa</sub> &#x26; time [days]</td>
<td align="right">&#x2212;0.107</td>
<td align="right">0.466</td>
</tr>
<tr>
<td align="left">VO<sub>2RCP</sub> &#x26; time [days]</td>
<td align="right">&#x2212;0.258</td>
<td align="right">0.073</td>
</tr>
<tr>
<td align="left">VO<sub>2RCPa</sub> &#x26; time [days]</td>
<td align="right">&#x2212;0.249</td>
<td align="right">0.084</td>
</tr>
<tr>
<td align="left">VO<sub>2max</sub> and time [days]</td>
<td align="right">&#x2212;0.197</td>
<td align="right">0.175</td>
</tr>
<tr>
<td align="left">VO<sub>2maxa</sub> and time [days]</td>
<td align="right">&#x2212;0.182</td>
<td align="right">0.211</td>
</tr>
<tr>
<td align="left">VE<sub>RCP</sub> &#x26; time [days]</td>
<td align="right">&#x2212;0.181</td>
<td align="right">0.212</td>
</tr>
<tr>
<td align="left">HR<sub>AT</sub> &#x26; time [days]</td>
<td align="right">&#x2212;0.165</td>
<td align="right">0.258</td>
</tr>
<tr>
<td align="left">HR<sub>RCP</sub> &#x26; time [days]</td>
<td align="right">
<bold>&#x2212;0.301</bold>
</td>
<td align="right">
<bold>0.036</bold>
</td>
</tr>
<tr>
<td align="left">HR<sub>max</sub> &#x26; time [days]</td>
<td align="right">&#x2212;0.244</td>
<td align="right">0.091</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Abbreviations: BF, body fat (%); VO<sub>2AT</sub>, oxygen uptake at the anaerobic threshold (ml&#xb7;kg&#xb7;min<sup>-1</sup>); VO<sub>2ATa</sub>, absolute oxygen uptake at the anaerobic threshold; (ml&#xb7;kg&#xb7;min<sup>-1</sup>); HR<sub>AT</sub>, heart rate at the anaerobic threshold (beats&#xb7;min<sup>-1</sup>); VO<sub>2RCP</sub>, oxygen uptake at the respiratory compensation point (ml&#xb7;kg&#xb7;min<sup>-1</sup>); VO<sub>2RCPa</sub>, oxygen uptake at the respiratory compensation point (ml&#xb7;min<sup>-1</sup>); HR<sub>RCP</sub>, heart rate at the respiratory compensation point (beats&#xb7;min<sup>-1</sup>); VE<sub>RCP</sub>, pulmonary ventilation at the respiratory compensation point (l&#xa0;min<sup>-1</sup>); VO<sub>2max</sub>, maximal oxygen uptake (ml&#xb7;kg&#xb7;min<sup>-1</sup>); VO<sub>2maxa</sub>, absolute maximal oxygen uptake; (ml&#xb7;min<sup>-1</sup>); HR<sub>max</sub>, maximal heart rate. Significant values (<italic>p</italic> &#x3c; 0.05) were bolded.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T6" position="float">
<label>TABLE 6</label>
<caption>
<p>Spearman&#x2019;s rank correlation coefficient for CPET and physiologic results adjusted to the time.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Variable</th>
<th align="center">r-Spearman</th>
<th align="center">
<italic>p</italic>-value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Fat mass and time [days]</td>
<td align="right">
<bold>0.331</bold>
</td>
<td align="right">
<bold>0.020</bold>
</td>
</tr>
<tr>
<td align="left">Fat-free mass and time [days]</td>
<td align="right">-0.067</td>
<td align="right">0.645</td>
</tr>
<tr>
<td align="left">BMI &#x26; time [days]</td>
<td align="right">0.146</td>
<td align="right">0.318</td>
</tr>
<tr>
<td align="left">Speed/power at &#x26; time [days]</td>
<td align="right">
<bold>-0.288</bold>
</td>
<td align="right">
<bold>0.0445</bold>
</td>
</tr>
<tr>
<td align="left">Speed/power at RCP &#x26; time [days]</td>
<td align="right">-0.241</td>
<td align="right">0.095</td>
</tr>
<tr>
<td align="left">Maximal speed/power and time [days]</td>
<td align="right">-0.212</td>
<td align="right">0.143</td>
</tr>
<tr>
<td align="left">VE<sub>AT</sub> &#x26; time [days]</td>
<td align="right">-0.1299</td>
<td align="right">0.373</td>
</tr>
<tr>
<td align="left">VE<sub>max</sub> &#x26; time [days]</td>
<td align="right">-0.071</td>
<td align="right">0.629</td>
</tr>
<tr>
<td align="left">Lac<sub>AT</sub> &#x26; time [days]</td>
<td align="right">0.015</td>
<td align="right">0.927</td>
</tr>
<tr>
<td align="left">Lac<sub>RCP</sub> &#x26; time [days]</td>
<td align="right">-0.257</td>
<td align="right">0.118</td>
</tr>
<tr>
<td align="left">Lac<sub>max</sub> and time [days]</td>
<td align="right">-0.281</td>
<td align="right">0.155</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Abbreviations: BMI, body mass index (kg&#xb7;m<sup>-2</sup>); AT, anaerobic threshold; RCP, respiratory compensation point; VE<sub>AT</sub>, pulmonary ventilation at the anaerobic threshold (l&#xb7;min<sup>-1</sup>); VE<sub>max</sub>, maximal pulmonary ventilation (l&#xb7;min<sup>-1</sup>); Lac<sub>AT</sub>, blood lactate concentration at the anaerobic threshold (mmol&#xb7;L<sup>-1</sup>); Lac<sub>RCP</sub>, blood lactate concentration at the respiratory compensation point (mmol&#xb7;L<sup>-1</sup>); Lac<sub>max</sub>, maximal blood lactate concentration (mmol&#xb7;L<sup>-1</sup>). Fat mass and fat-free mass are presented in kg. Speed is presented in km&#xb7;h<sup>-1</sup>, while power is presented in Watts. Significant values (<italic>p</italic> &#x3c; 0.05) were bolded.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>The harmful influence of mild COVID-19 infection on CPET performance in a group of endurance athletes was demonstrated. The main findings are: (1) COVID-19 infection causes deterioration of exercise and body anthropometric parameters both on professional and amateur EA and (2) the impact of infection was the most significant for HR and VO<sub>2</sub>, and (3) even the mild COVID-19 infection should be considered as a limiting factor for exercise performance. We noticed the weight and BMI increases. Interestingly, the percentage of BF and FATM is lower after contracting COVID-19.</p>
<p>Among our subjects, we noticed a difference in body composition before and after contracting COVID-19. Patients during the infection are at risk of weight loss due to weakness, fever, decreased appetite and taste, depending on the advancement of the disease (<xref ref-type="bibr" rid="B50">Yang et al., 2020</xref>). Factors that correlate with weight loss include: raised C-reactive protein levels, impaired kidney function, and long duration of illness (<xref ref-type="bibr" rid="B4">Anker et al., 2021</xref>). Among our patients, both weight and BMI increased, which is not typical for the immediate time of the disease. This may be due to the passage of time since the first test, as well as the lockdown and limited opportunities for physical activity and changes in eating habits such as overeating (<xref ref-type="bibr" rid="B26">Martinez-Ferran et al., 2020</xref>). A systematic review was created, which among respondents during the pandemic noted an increase in food consumption by 36.3%&#x2013;59.6% of respondents and a decrease in physical activity by 67.4%&#x2013;61.4% (<xref ref-type="bibr" rid="B7">Chew and Lopez, 2021</xref>). An unexpected decrease in BF and FATM with weight gain may be due to a specific diet aimed at minimizing the increase in body fat in athletes (<xref ref-type="bibr" rid="B15">Iraki et al., 2019</xref>) Adequate amount of protein in the diet and properly workouts support the burning of body fat and promote the retention of lean mass (<xref ref-type="bibr" rid="B33">Ruiz-Castellano et al., 2021</xref>).</p>
<p>Physical training allows one to exert higher intensities with lower lactate levels (<xref ref-type="bibr" rid="B34">San-Millan and Brooks, 2018</xref>) and increase VO<sub>2max</sub>, which constitutes the basis for preparation to achieve optimal sports results (<xref ref-type="bibr" rid="B35">Seiler, 2010</xref>). Maintenance of physical fitness requires adherence to the exercise and training regimen. On the contrary, conditions of the COVID-19 pandemic presented many risks of reverse effects (<xref ref-type="bibr" rid="B18">Jodczyk et al., 2022</xref>). He disease itself may injure multiple organ systems, the more severe it is. However, even a relatively mild course of the illness has been associated with persistent health complications (<xref ref-type="bibr" rid="B43">van Voorthuizen et al., 2022</xref>). It is worth emphasizing because none of our study participants was hospitalized because of COVID-19 infection. One of the studies also showed that healthy patients who experienced mild COVID-19 have reduced efficiency compared to the control group, including reduction in peak VO2 associated with impaired systemic oxygen extraction, additionally, convalescents also showed greater respiratory failure (<xref ref-type="bibr" rid="B37">Singh et al., 2022</xref>). Convalescents report reduced daily physical activity, which in turn may lead to a decrease in efficiency (<xref ref-type="bibr" rid="B9">Delbressine et al., 2021</xref>). Despite the occurrence of side effects even in people with moderate to mild COVID-19, it is important to remember that these effects are potentially less persistent than in patients with severe COVID-19 (<xref ref-type="bibr" rid="B16">Jimeno-Almazan et al., 2022</xref>).</p>
<p>Evidence of lung fibrosis, although not common (in 1.1% of cases), was found even in mild-to-moderate cases of COVID-19 (<xref ref-type="bibr" rid="B49">Xia et al., 2020</xref>). Autonomic nervous system dysregulation in young patients, measured by HR variability and partly attenuated by physical activity, was also reported (<xref ref-type="bibr" rid="B12">Freire et al., 2022</xref>). A study of college athletes revealed signs of ongoing myocarditis or earlier myocardial injury in cardiac magnetic resonance performed up to 53&#xa0;days after a period of quarantine (<xref ref-type="bibr" rid="B31">Rajpal et al., 2021</xref>). Muscle deconditioning was proposed to mainly limit CPET results in COVID-19 survivors (<xref ref-type="bibr" rid="B32">Rinaldo et al., 2021</xref>). Among possible mechanisms involved are direct cell invasion, ACE2 downregulation, and inflammation, as well as prolonged bedrest and hypoxia in severe cases (<xref ref-type="bibr" rid="B36">Seixas et al., 2022</xref>). Deconditioning due to hypoactivity occurs rapidly, e.g., just 5&#xa0;days may be enough to negatively affect muscle strength or oxidative capacity, induce fiber atrophy and disrupt protein balance (<xref ref-type="bibr" rid="B11">Fovet et al., 2021</xref>). Given ordinary conditions, 8&#xa0;weeks of a sedentary lifestyle was found to lead to wasted 6-week training results in terms of VO<sub>2</sub> (<xref ref-type="bibr" rid="B13">Fritzen et al., 2020</xref>). It is also noteworthy that a pandemic does not mean quarantine itself. Apart from COVID-19 illness, legal and social conditions promoted physical inactivity by encouraging social distancing and restricting access to sports facilities, sometimes even prohibiting unnecessary leaving residential buildings (<xref ref-type="bibr" rid="B48">Wunsch et al., 2022</xref>).</p>
<p>Our results demonstrate the cumulative negative effect of the pandemic on physical fitness among endurance athletes and show different infection consequences for both treadmill and cycle ergometry. These findings are in line with the previous research, as Price et al. confirmed that both modalities differed (<xref ref-type="bibr" rid="B30">Price et al., 2022</xref>), the choice of device was adapted to the leading discipline of the subject, differences may have occurred in VO<sub>2</sub> and HR at maximum exertion, at AT and at RCP between cycling and running CPET testing, in both males and females. In our participants, we found lower VO<sub>2max</sub> and earlier lactate accumulation during CPET. Meanwhile, there are few studies that demonstrate the change in CPET performance after COVID-19 infection in endurance athletes and compare them with healthy controls. Similarly, to our results, in a sample of elite cross-country skiers&#x2014;asymptomatic during evaluation, 4&#x2013;6&#xa0;weeks after COVID-19 diagnosis&#x2014;CPET revealed lower VO<sub>2max</sub>, VE, HR, and O<sub>2pulse</sub> when compared to the control group. On the other hand, in contrast to our observations, there was no statistical difference in VO<sub>2max</sub> between post-COVID-19 soccer players and controls at the age of 18&#x2013;35. Although, the trend towards reduced VO<sub>2</sub> was visible. It is also worth noting that we recorded a decline in VO<sub>2</sub> of 2&#x2013;4&#xa0;mlkg&#xb7;min<sup>&#x2212;1</sup> over about 1.5&#xa0;years between CPETs (exact interval was 591.67 &#xb1; 282.24&#xa0;days; see <xref ref-type="table" rid="T1">Table 1</xref>). According to reference standards provided by <xref ref-type="bibr" rid="B19">Kaminsky et al. (2015</xref>) VO<sub>2</sub> should decrease by about 4&#x2013;5&#xa0;mlkg&#xb7;min<sup>&#x2212;1</sup> over 10&#xa0;years. Our EAs experienced a much more dynamic decline in VO<sub>2</sub> than only based on age. Hence, it is worth considering the previous COVID-19 infection as a possible influencing variable. Resting and maximal HR, VE, and blood pressure were not changed compared to healthy controls, as well as other reported CPET parameters. The research excluded non-competitive athletes and required recovery from infection within the previous 30&#xa0;days, which means earlier assessment than used in this study. Consequently, only 5 out of 24 examined post-COVID-19 soccer players showed no illness symptoms (<xref ref-type="bibr" rid="B22">Komici et al., 2021</xref>). Likewise, no deterioration of CPET performance was observed in elite swimmers from National Swim Team Hungary after a mild COVID-19 infection (<xref ref-type="bibr" rid="B8">Csulak et al., 2021</xref>). It is worth noting that physical performance declined with age to various degrees between participants, but age was also one of the contributing factors (<xref ref-type="bibr" rid="B46">Wiecha et al., 2022</xref>). So far, it has been postulated that training experience may reduce the decline in HR and VO<sub>2</sub> observed with age (<xref ref-type="bibr" rid="B41">Tanaka and Matsuura, 1984</xref>; <xref ref-type="bibr" rid="B19">Kaminsky et al., 2015</xref>). The less trained EAs usually noted a steeper decline. In our study, two most significantly different variables before and after infection, i.e., HR (at AT and RCP) and VO<sub>2</sub> (at AT, RCP and max) after adjusting for training experience did not show significant differences (except HR for subgroup with 6&#x2013;10&#xa0;years of training). Thus, underwent COVID-19 infection could be a contributing factor and cause a steeper deterioration of endurance capacity.</p>
<p>The maximal exercise capacity, formulated in metabolic equivalents of the task (MET) was linked with the risk of hospitalization due to COVID-19 with each 1 MET higher indicating odds lower by 13% (<xref ref-type="bibr" rid="B6">Brawner et al., 2021</xref>). In addition, age-related mortality of the disease remains in close contact with VO<sub>2max</sub> declining over the course of the human lifespan. SARS-CoV-2 infection may unfavorably influence lipid metabolism pathways and cause mitochondrial dysfunction in a similar way to aging. Therefore, there could be a harmful cumulative effect on the athletes with age, as well as protection for physically fit people (<xref ref-type="bibr" rid="B40">Spedding et al., 2022</xref>). Despite COVID-19 infection, in our study, athletes&#x2019; muscle deconditioning due to pandemic-related lower physical activity might be enough to explain the results. What is more, lactate accumulation is known as an immunomodulatory factor because of its connection with IL-6 production, the activity of dendritic cells, or T-cell responses, which explains some of the anti-inflammatory characteristics of physical activity. Hence, it was even hypothesized that increasing the anaerobic threshold may protect against COVID-19 complications (<xref ref-type="bibr" rid="B1">AbdelMassih et al., 2021</xref>) and our findings may even indicate a pro-inflammatory aspect of the pandemic.</p>
<p>As sports performance, presented changes in CPET parameters need to be assessed in terms of the smallest worthwhile change (SWC). Most of them decreased by about 0.4 of baseline SD. The biggest post-COVID-19 declines were observed in VO<sub>2</sub> at RCP (0.46 SD) and absolute VO<sub>2</sub> at RCP (0.51 SD). This constitutes a visible factor during competitions if we define SWC as 0.2 of the baseline SD (<xref ref-type="bibr" rid="B25">Lindberg et al., 2022</xref>). Our other results are somewhat inconclusive. Division by measurement method (cycle ergometer or treadmill) indicated some statistical differences, yet they were most likely a matter of the small size of the groups distinguished. Besides, the time-dependence of BF percentage and FATM or power at the AT and HR at the RCP cannot be discriminated among the infection, detraining, and the passage of time.</p>
<sec id="s4-1">
<title>Practical and clinical implications</title>
<p>Our results have practical application in both clinical circumstances and during training prescription. They provide valuable information for Medical professionals and Personal trainers. Knowing the potential consequences of mild COVID-19 will help to adjust the intensity of exercise properly to keep it safe for the athlete and select proper recovery strategies (<xref ref-type="bibr" rid="B47">Wisniowski et al., 2022</xref>). In addition, it will allow physicians to prescribe proper treatment or cardiac rehabilitation protocols for patients after COVID-19 (<xref ref-type="bibr" rid="B21">Kasiak et al., 2022b</xref>). They can also facilitate the evaluation of the effectiveness of cardiac rehabilitation programs.</p>
</sec>
<sec id="s4-2">
<title>Limitations</title>
<p>The limitation of the study is the relatively long period between both CPET evaluations. It may contribute to some degree to changes in exercise and anthropometric data parameters. Subjects underwent CPET in different periods of the season (i.e., competition preparation time or post-season recovery period). Perhaps they could be at different fitness level at the time of CPET. Additionally, study cohort is not numerous. Above-mentioned limitations resulted from study character, which was an observational study, not a clinical trial. We are aware of the existing limitations, thus we recommend careful extrapolation of the provided results and we suggest that their highest repeatability would be seen in similar population of endurance trained individuals. Furthermore, wer recommend future research to validate our findings.</p>
</sec>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>A mild COVID-19 infection resulted in a decrease in professional and amateur EA&#x2019;s CPET performance. The most significant changes were observed for VO<sub>2,</sub> and HR. Medical Professionals and Training Specialists should be aware of the consequences of a mild COVID-19 infection in order to recommend optimal therapeutic methods and properly adjust the intensity of training. The results are a valuable addition to the current state of knowledge when preparing Return to Play clinical protocols and guidelines.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s7">
<title>Ethics statement</title>
<p>The studies involving human participants were reviewed and approved by Bioethics Committee, Medical University of Warsaw; 3C Pawi&#x144;skiego, 02-106 Warsaw, Poland. The patients/participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s8">
<title>Author contributions</title>
<p>D&#x15a;, SW, and ML: conceptualization and resources. D&#x15a; and AM: investigation. D&#x15a;, SW, JG, and ML: statistical analysis. D&#x15a;, KU, and PK: writing- original draft preparation. D&#x15a;, KU, and PK: writing-review, and editing. D&#x15a; and AM: supervision. All authors have read and agreed to the published version of the manuscript.</p>
</sec>
<sec id="s9">
<title>Funding</title>
<p>This study was funded by the affiliated university (Medical University of Warsaw).</p>
</sec>
<ack>
<p>The authors thank Robert Ko&#x142;aczy&#x144;ski for his participation in transferring the data and Piotr D&#x142;ugo&#x142;ecki for preparing the text.</p>
</ack>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>Authors DS and AM are a board members of the company Polish Society of Lifestyle Medicine. DS and AM do not receive any salary from the Polish Society of Lifestyle Medicine.</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>AbdelMassih</surname>
<given-names>A. F.</given-names>
</name>
<name>
<surname>Menshawey</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hozaien</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kamel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mishriky</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Husseiny</surname>
<given-names>R. J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>The potential use of lactate blockers for the prevention of COVID-19 worst outcome, insights from exercise immunology</article-title>. <source>Med. Hypotheses</source> <volume>148</volume>, <fpage>110520</fpage>. <pub-id pub-id-type="doi">10.1016/j.mehy.2021.110520</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Aly</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Bowe</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Long COVID after breakthrough SARS-CoV-2 infection</article-title>. <source>Nat. Med.</source> <volume>28</volume> (<issue>7</issue>), <fpage>1461</fpage>&#x2013;<lpage>1467</lpage>. <pub-id pub-id-type="doi">10.1038/s41591-022-01840-0</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ali</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Kunugi</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Skeletal muscle damage in COVID-19: A call for action</article-title>. <source>Med. Kaunas.</source> <volume>57</volume> (<issue>4</issue>), <fpage>372</fpage>. <pub-id pub-id-type="doi">10.3390/medicina57040372</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anker</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Landmesser</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>von Haehling</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Coats</surname>
<given-names>A. J. S.</given-names>
</name>
<name>
<surname>Anker</surname>
<given-names>S. D.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Weight loss, malnutrition, and cachexia in COVID-19: Facts and numbers</article-title>. <source>J. Cachexia Sarcopenia Muscle</source> <volume>12</volume> (<issue>1</issue>), <fpage>9</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1002/jcsm.12674</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baratella</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ruaro</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Marrocchio</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Starvaggi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Salton</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Giudici</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Interstitial lung disease at high resolution CT after SARS-CoV-2-related acute respiratory distress syndrome according to pulmonary segmental anatomy</article-title>. <source>J. Clin. Med.</source> <volume>10</volume> (<issue>17</issue>), <fpage>3985</fpage>. <pub-id pub-id-type="doi">10.3390/jcm10173985</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brawner</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Ehrman</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Bole</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kerrigan</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Parikh</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>B. K.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Inverse relationship of maximal exercise capacity to hospitalization secondary to coronavirus disease 2019</article-title>. <source>Mayo Clin. Proc.</source> <volume>96</volume> (<issue>1</issue>), <fpage>32</fpage>&#x2013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/j.mayocp.2020.10.003</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chew</surname>
<given-names>H. S. J.</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Global impact of COVID-19 on weight and weight-related behaviors in the adult population: A scoping review</article-title>. <source>Int. J. Environ. Res. Public Health</source> <volume>18</volume> (<issue>4</issue>), <fpage>1876</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph18041876</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Csulak</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Petrov</surname>
<given-names>&#xc1;.</given-names>
</name>
<name>
<surname>Kov&#xe1;ts</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tokodi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lakatos</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kov&#xe1;cs</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>The impact of COVID-19 on the preparation for the tokyo olympics: A comprehensive performance assessment of top swimmers</article-title>. <source>Int. J. Environ. Res. Public Health</source> <volume>18</volume> (<issue>18</issue>), <fpage>9770</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph18189770</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delbressine</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Machado</surname>
<given-names>F. V. C.</given-names>
</name>
<name>
<surname>Goertz</surname>
<given-names>Y. M. J.</given-names>
</name>
<name>
<surname>Van Herck</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Meys</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Houben-Wilke</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>The impact of post-COVID-19 syndrome on self-reported physical activity</article-title>. <source>Int. J. Environ. Res. Public Health</source> <volume>18</volume> (<issue>11</issue>), <fpage>6017</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph18116017</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fikenzer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kogel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pietsch</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lavall</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>St&#xf6;be</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rudolph</surname>
<given-names>U.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>SARS-CoV2 infection: Functional and morphological cardiopulmonary changes in elite handball players</article-title>. <source>Sci. Rep.</source> <volume>11</volume> (<issue>1</issue>), <fpage>17798</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-97120-x</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fovet</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Guilhot</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Montel</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Delobel</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Roumanille</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Early deconditioning of human skeletal muscles and the effects of a thigh cuff countermeasure</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume> (<issue>21</issue>), <fpage>12064</fpage>. <pub-id pub-id-type="doi">10.3390/ijms222112064</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freire</surname>
<given-names>A. P. C. F.</given-names>
</name>
<name>
<surname>Lira</surname>
<given-names>F. S.</given-names>
</name>
<name>
<surname>Morano</surname>
<given-names>A. E. A.</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Coelho-E-Silva</surname>
<given-names>M.-J.</given-names>
</name>
<name>
<surname>Caseiro</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Role of body mass and physical activity in autonomic function modulation on post-COVID-19 condition: An observational subanalysis of fit-COVID study</article-title>. <source>Int. J. Environ. Res. Public Health</source> <volume>19</volume> (<issue>4</issue>), <fpage>2457</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph19042457</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fritzen</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Qadri</surname>
<given-names>K. A. N.</given-names>
</name>
<name>
<surname>Th&#xf8;gersen</surname>
<given-names>F. D.</given-names>
</name>
<name>
<surname>Krag</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>&#xd8;rngreen</surname>
<given-names>M. C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Effect of aerobic exercise training and deconditioning on oxidative capacity and muscle mitochondrial enzyme machinery in young and elderly individuals</article-title>. <source>J. Clin. Med.</source> <volume>9</volume> (<issue>10</issue>), <fpage>3113</fpage>. <pub-id pub-id-type="doi">10.3390/jcm9103113</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gruba</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kasiak</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Gebarowska</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Adamczyk</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sikora</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jodczyk</surname>
<given-names>A. M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>PaLS study of sleep deprivation and mental health consequences of the COVID-19 pandemic among university students: A cross-sectional survey</article-title>. <source>Int. J. Environ. Res. Public Health</source> <volume>18</volume> (<issue>18</issue>), <fpage>9581</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph18189581</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iraki</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fitschen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Espinar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Helms</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Nutrition recommendations for bodybuilders in the off-season: A narrative review</article-title>. <source>Sports (Basel)</source> <volume>7</volume> (<issue>7</issue>), <fpage>154</fpage>. <pub-id pub-id-type="doi">10.3390/sports7070154</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jimeno-Almazan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Martinez-Cava</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Buendia-Romero</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Franco-Lopez</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sanchez-Agar</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Sanchez-Alcaraz</surname>
<given-names>B. J.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Relationship between the severity of persistent symptoms, physical fitness, and cardiopulmonary function in post-COVID-19 condition. A population-based analysis</article-title>. <source>Intern. Emerg. Med.</source> <volume>17</volume> (<issue>8</issue>), <fpage>2199</fpage>&#x2013;<lpage>2208</lpage>. <pub-id pub-id-type="doi">10.1007/s11739-022-03039-0</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jodczyk</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Gruba</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sikora</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Kasiak</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Gebarowska</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Adamczyk</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>PaLS study: How has the COVID-19 pandemic influenced physical activity and nutrition? Observations a year after the outbreak of the pandemic</article-title>. <source>Int. J. Environ. Res. Public Health</source> <volume>18</volume> (<issue>18</issue>), <fpage>9632</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph18189632</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jodczyk</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Kasiak</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Adamczyk</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gebarowska</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sikora</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gruba</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>PaLS study: Tobacco, alcohol and drugs usage among polish university students in the context of stress caused by the COVID-19 pandemic</article-title>. <source>Int. J. Environ. Res. Public Health</source> <volume>19</volume> (<issue>3</issue>), <fpage>1261</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph19031261</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaminsky</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Arena</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Reference standards for cardiorespiratory fitness measured with cardiopulmonary exercise testing: Data from the fitness registry and the importance of exercise national database</article-title>. <source>Mayo Clin. Proc.</source> <volume>90</volume> (<issue>11</issue>), <fpage>1515</fpage>&#x2013;<lpage>1523</lpage>. <pub-id pub-id-type="doi">10.1016/j.mayocp.2015.07.026</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasiak</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Adamczyk</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Jodczyk</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Kapron</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lisowska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mamcarz</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2022a</year>). <article-title>COVID-19 pandemic consequences among individuals with eating disorders on a clinical sample in Poland-A cross-sectional study</article-title>. <source>Int. J. Environ. Res. Public Health</source> <volume>19</volume> (<issue>14</issue>), <fpage>8484</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph19148484</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasiak</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Buchalska</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kowalczyk</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wyszomirski</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Krzowski</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Grabowski</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2022b</year>). <article-title>The path of a cardiac patient-from the first symptoms to diagnosis to treatment: Experiences from the tertiary Care center in Poland</article-title>. <source>J. Clin. Med.</source> <volume>11</volume> (<issue>18</issue>), <fpage>5276</fpage>. <pub-id pub-id-type="doi">10.3390/jcm11185276</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Komici</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bianco</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Perrotta</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dello Iacono</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bencivenga</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>D&#x27;Agnano</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Clinical characteristics, exercise capacity and pulmonary function in post-COVID-19 competitive athletes</article-title>. <source>J. Clin. Med.</source> <volume>10</volume> (<issue>14</issue>), <fpage>3053</fpage>. <pub-id pub-id-type="doi">10.3390/jcm10143053</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lach</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wiecha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sliz</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zaborski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cieslinski</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>HR max prediction based on age, body composition, fitness level, testing modality and sex in physically active population</article-title>. <source>Front. Physiol.</source> <volume>12</volume>, <fpage>695950</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2021.695950</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lemes</surname>
<given-names>I. R.</given-names>
</name>
<name>
<surname>Smaira</surname>
<given-names>F. I.</given-names>
</name>
<name>
<surname>Ribeiro</surname>
<given-names>W. J. D.</given-names>
</name>
<name>
<surname>Favero</surname>
<given-names>N. K.</given-names>
</name>
<name>
<surname>Matos</surname>
<given-names>L. D. N. J.</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>A. L. d. S.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Acute and post-acute COVID-19 presentations in athletes: A systematic review and meta-analysis</article-title>. <source>Br. J. Sports Med.</source> <volume>56</volume> (<issue>16</issue>), <fpage>941</fpage>&#x2013;<lpage>947</lpage>. <pub-id pub-id-type="doi">10.1136/bjsports-2022-105583</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lindberg</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Solberg</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bj&#xf8;rnsen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Helland</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>R&#xf8;nnestad</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Thorsen Frank</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Strength and power testing of athletes: A multicenter study of test&#x2013;retest reliability</article-title>. <source>Int. J. Sports Physiol. Perform.</source> <volume>17</volume> (<issue>7</issue>), <fpage>1103</fpage>&#x2013;<lpage>1110</lpage>. <pub-id pub-id-type="doi">10.1123/ijspp.2021-0558</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez-Ferran</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>de la Guia-Galipienso</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sanchis-Gomar</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Pareja-Galeano</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Metabolic impacts of confinement during the COVID-19 pandemic due to modified diet and physical activity habits</article-title>. <source>Nutrients</source> <volume>12</volume> (<issue>6</issue>), <fpage>1549</fpage>. <pub-id pub-id-type="doi">10.3390/nu12061549</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Modica</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bianco</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sollazzo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Di Murro</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Monti</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cammarano</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Myocarditis in athletes recovering from COVID-19: A systematic review and meta-analysis</article-title>. <source>Int. J. Environ. Res. Public Health</source> <volume>19</volume> (<issue>7</issue>), <fpage>4279</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph19074279</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moulson</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gustus</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Scirica</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Petek</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Vanatta</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Churchill</surname>
<given-names>T. W.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Diagnostic evaluation and cardiopulmonary exercise test findings in young athletes with persistent symptoms following COVID-19</article-title>. <source>Br. J. Sports Med.</source> <volume>56</volume> (<issue>16</issue>), <fpage>927</fpage>&#x2013;<lpage>932</lpage>. <pub-id pub-id-type="doi">10.1136/bjsports-2021-105157</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nasserie</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hittle</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>S. N.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: A systematic review</article-title>. <source>JAMA Netw. Open</source> <volume>4</volume> (<issue>5</issue>), <fpage>e2111417</fpage>. <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.11417</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Price</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wiecha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cie&#x15b;li&#x144;ski</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>&#x15a;li&#x17c;</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kasiak</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Lach</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Differences between treadmill and cycle ergometer cardiopulmonary exercise testing results in triathletes and their association with body composition and body mass index</article-title>. <source>Int. J. Environ. Res. Public Health</source> <volume>19</volume> (<issue>6</issue>), <fpage>3557</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph19063557</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajpal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Borchers</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zareba</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Obarski</surname>
<given-names>T. P.</given-names>
</name>
<name>
<surname>Simonetti</surname>
<given-names>O. P.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection</article-title>. <source>JAMA Cardiol.</source> <volume>6</volume> (<issue>1</issue>), <fpage>116</fpage>&#x2013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1001/jamacardio.2020.4916</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rinaldo</surname>
<given-names>R. F.</given-names>
</name>
<name>
<surname>Mondoni</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Parazzini</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Pitari</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Brambilla</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Luraschi</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors</article-title>. <source>Eur. Respir. J.</source> <volume>58</volume> (<issue>2</issue>), <fpage>2100870</fpage>. <pub-id pub-id-type="doi">10.1183/13993003.00870-2021</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruiz-Castellano</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Espinar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Contreras</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mata</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Aragon</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Martinez-Sanz</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Achieving an optimal fat loss phase in resistance-trained athletes: A narrative review</article-title>. <source>Nutrients</source> <volume>13</volume> (<issue>9</issue>), <fpage>3255</fpage>. <pub-id pub-id-type="doi">10.3390/nu13093255</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>San-Millan</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>G. A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Assessment of metabolic flexibility by means of measuring blood lactate, fat, and carbohydrate oxidation responses to exercise in professional endurance athletes and less-fit individuals</article-title>. <source>Sports Med.</source> <volume>48</volume> (<issue>2</issue>), <fpage>467</fpage>&#x2013;<lpage>479</lpage>. <pub-id pub-id-type="doi">10.1007/s40279-017-0751-x</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seiler</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>What is best practice for training intensity and duration distribution in endurance athletes?</article-title> <source>Int. J. Sports Physiol. Perform.</source> <volume>5</volume> (<issue>3</issue>), <fpage>276</fpage>&#x2013;<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1123/ijspp.5.3.276</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seixas</surname>
<given-names>M. L. G. A.</given-names>
</name>
<name>
<surname>Mitre</surname>
<given-names>L. P.</given-names>
</name>
<name>
<surname>Shams</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lanzuolo</surname>
<given-names>G. B.</given-names>
</name>
<name>
<surname>Bartolomeo</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>E. A.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Unraveling muscle impairment associated with COVID-19 and the role of 3D culture in its investigation</article-title>. <source>Front. Nutr.</source> <volume>9</volume>, <fpage>825629</fpage>. <pub-id pub-id-type="doi">10.3389/fnut.2022.825629</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Joseph</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Heerdt</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Cullinan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lutchmansingh</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Gulati</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Persistent exertional intolerance after COVID-19: Insights from invasive cardiopulmonary exercise testing</article-title>. <source>Chest</source> <volume>161</volume> (<issue>1</issue>), <fpage>54</fpage>&#x2013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.chest.2021.08.010</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sittichai</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Parasin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Saokaew</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kanchanasurakit</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kayod</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Praikaew</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Effects of physical activity on the severity of illness and mortality in COVID-19 patients: A systematic review and meta-analysis</article-title>. <source>Front. Physiol.</source> <volume>13</volume>, <fpage>1030568</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2022.1030568</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sparrow</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Brosseau</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Osterholm</surname>
<given-names>M. T.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Protecting olympic participants from covid-19 &#x2014; the urgent need for a risk-management approach</article-title>. <source>N. Engl. J. Med.</source> <volume>385</volume> (<issue>1</issue>), <fpage>e2</fpage>. <pub-id pub-id-type="doi">10.1056/NEJMp2108567</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spedding</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Marvaud</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Marck</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Delarochelambert</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Toussaint</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Aging, VO2 max, entropy, and COVID-19</article-title>. <source>Indian J. Pharmacol.</source> <volume>54</volume> (<issue>1</issue>), <fpage>58</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.4103/ijp.ijp_442_21</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanaka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Matsuura</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>1984</year>). <article-title>Marathon performance, anaerobic threshold, and onset of blood lactate accumulation</article-title>. <source>J. Appl. Physiol. Respir. Environ. Exerc. Physiol.</source> <volume>57</volume> (<issue>3</issue>), <fpage>640</fpage>&#x2013;<lpage>643</lpage>. <pub-id pub-id-type="doi">10.1152/jappl.1984.57.3.640</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ulaszewska</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jodczyk</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>D&#x142;ugo&#x142;&#x119;cki</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Emerla</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sta&#x144;ska</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kasiak</surname>
<given-names>P. S.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Factors associated with willingness to receive a COVID-19 vaccine in adult polish population&#x2014;a cross-sectional survey</article-title>. <source>Vaccines</source> <volume>10</volume> (<issue>10</issue>), <fpage>1715</fpage>. <pub-id pub-id-type="doi">10.3390/vaccines10101715</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Voorthuizen</surname>
<given-names>E. L.</given-names>
</name>
<name>
<surname>van Helvoort</surname>
<given-names>H. A. C.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>van den Heuvel</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>van den Borst</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Persistent exertional dyspnea and perceived exercise intolerance after mild COVID-19: A critical role for breathing dysregulation?</article-title> <source>Phys. Ther.</source> <volume>102</volume> (<issue>10</issue>), <fpage>pzac105</fpage>. <pub-id pub-id-type="doi">10.1093/ptj/pzac105</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Paulson</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Pease</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Comfort</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Estimating excess mortality due to the COVID-19 pandemic: A systematic analysis of COVID-19-related mortality, 2020&#x2013;21</article-title>. <source>Lancet</source> <volume>399</volume> (<issue>10334</issue>), <fpage>1513</fpage>&#x2013;<lpage>1536</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(21)02796-3</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Washif</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Farooq</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Krug</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Pyne</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Verhagen</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Training during the COVID-19 lockdown: Knowledge, beliefs, and practices of 12, 526 athletes from 142 countries and six continents</article-title>. <source>Sports Med.</source> <volume>52</volume> (<issue>4</issue>), <fpage>933</fpage>&#x2013;<lpage>948</lpage>. <pub-id pub-id-type="doi">10.1007/s40279-021-01573-z</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiecha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cieslinski</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kasiak</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Tota</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ambrozy</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Transferability of cardiopulmonary parameters between treadmill and cycle ergometer testing in male triathletes-prediction formulae</article-title>. <source>Int. J. Environ. Res. Public Health</source> <volume>19</volume> (<issue>3</issue>), <fpage>1830</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph19031830</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wisniowski</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cieslinski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jarocka</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kasiak</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Makaruk</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Pawliczek</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>The effect of pressotherapy on performance and recovery in the management of delayed onset muscle soreness: A systematic review and meta-analysis</article-title>. <source>J. Clin. Med.</source> <volume>11</volume> (<issue>8</issue>), <fpage>2077</fpage>. <pub-id pub-id-type="doi">10.3390/jcm11082077</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wunsch</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kienberger</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Niessner</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Changes in physical activity patterns due to the covid-19 pandemic: A systematic review and meta-analysis</article-title>. <source>Int. J. Environ. Res. Public Health</source> <volume>19</volume> (<issue>4</issue>), <fpage>2250</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph19042250</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Friedemann</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>The course of mild and moderate COVID-19 infections&#x2014;the unexpected long-lasting challenge</article-title>. <source>Open Forum Infect. Dis.</source> <volume>7</volume> (<issue>9</issue>), <fpage>ofaa286</fpage>. <pub-id pub-id-type="doi">10.1093/ofid/ofaa286</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Clinical and epidemiological characteristics of COVID-19 patients in chongqing China</article-title>. <source>Front. Public Health</source> <volume>8</volume>, <fpage>244</fpage>. <pub-id pub-id-type="doi">10.3389/fpubh.2020.00244</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients</article-title>. <source>Natl. Sci. Rev.</source> <volume>7</volume> (<issue>6</issue>), <fpage>998</fpage>&#x2013;<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1093/nsr/nwaa041</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>